Buprenorphine Hcl And Naloxone Hcl Tablet
Product Images NDC 65162-416

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl And Naloxone Hcl (NDC 65162-416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

561287c0-figure-01 (Buprenorphine And Naloxone Sublingual Tablets 1)

Chemical structure of Buprenorphine, the active ingredient in Buprenorphine HCl and Naloxone HCl sublingual tablets by Amneal Pharmaceuticals LLC. The diagram shows the molecular arrangement including rings, hydroxyl groups, and a cyclopropylmethyl substituent.*

FDA Label Image

561287c0-figure-02 (Buprenorphine And Naloxone Sublingual Tablets 2)

Chemical structure diagram of Buprenorphine Hydrochloride Dihydrate, showing its molecular framework with hydroxyl, ketone, and tertiary amine groups, confirming its identity as an opioid analgesic ingredient.*

FDA Label Image

1 (Buprenorphine And Naloxone Sublingual Tablets 3)

An instructional illustration showing the placement of a sublingual tablet inside an open mouth. The diagram highlights the tongue lifted to expose the area beneath it, where the tablet is positioned, demonstrating proper administration of a sublingual tablet form of medication.*

FDA Label Image

2mg Label (Buprenorphine And Naloxone Sublingual Tablets 4)

Label for Buprenorphine and Naloxone Sublingual Tablets, USP 2 mg / 0.5 mg by Amneal Pharmaceuticals LLC. The label states each sublingual tablet contains 2 mg Buprenorphine and 0.5 mg Naloxone, with storage instructions and warnings to keep out of reach of children. The package contains 90 tablets, manufactured in Brookhaven, NY, and distributed from Glasgow, KY.*

FDA Label Image

8 mg Label (Buprenorphine And Naloxone Sublingual Tablets 5)

Label for Buprenorphine and Naloxone Sublingual Tablets USP, 8 mg/2 mg strength, supplied in a container of 90 tablets. The label shows the pill imprint, manufacturer Amneal Pharmaceuticals of NY LLC, and distributor Amneal Pharmaceuticals LLC. It includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.